212 related articles for article (PubMed ID: 35639233)
1. Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway.
Ibrahim WW; Abdel Rasheed NO
Inflammopharmacology; 2022 Oct; 30(5):1745-1758. PubMed ID: 35639233
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway.
Abdel Rasheed NO; Ibrahim WW
Life Sci; 2022 May; 297():120480. PubMed ID: 35278421
[TBL] [Abstract][Full Text] [Related]
3. Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
El-Shamarka ME; El-Sahar AE; Saad MA; Assaf N; Sayed RH
Life Sci; 2022 Jul; 300():120569. PubMed ID: 35472453
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
[TBL] [Abstract][Full Text] [Related]
5. Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
Abdelfattah MS; Badr SEA; Lotfy SA; Attia GH; Aref AM; Abdel Moneim AE; Kassab RB
Neurotox Res; 2020 Jan; 37(1):77-92. PubMed ID: 31332714
[TBL] [Abstract][Full Text] [Related]
6. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway.
Gopinath K; Sudhandiran G
Neuroscience; 2012 Dec; 227():134-43. PubMed ID: 22871521
[TBL] [Abstract][Full Text] [Related]
7. Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways.
Hamouda HA; Sayed RH; Eid NI; El-Sayeh BM
Neurochem Res; 2024 Apr; 49(4):1017-1033. PubMed ID: 38184805
[TBL] [Abstract][Full Text] [Related]
8. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
Thangarajan S; Ramachandran S; Krishnamurthy P
Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells.
Kulasekaran G; Ganapasam S
Mol Cell Biochem; 2015 Nov; 409(1-2):199-211. PubMed ID: 26280522
[TBL] [Abstract][Full Text] [Related]
11. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
[TBL] [Abstract][Full Text] [Related]
12. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
[TBL] [Abstract][Full Text] [Related]
13. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.
Elbaz EM; Helmy HS; El-Sahar AE; Saad MA; Sayed RH
Neurochem Int; 2019 Dec; 131():104548. PubMed ID: 31539560
[TBL] [Abstract][Full Text] [Related]
14. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya SN; Sumathi T
Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
[TBL] [Abstract][Full Text] [Related]
15. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
Hanna DM; Tadros MG; Khalifa AE
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():36-51. PubMed ID: 25689821
[TBL] [Abstract][Full Text] [Related]
16. Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington's disease like symptoms in rats.
Salman M; Sharma P; Alam MI; Tabassum H; Parvez S
Nutr Neurosci; 2022 Sep; 25(9):1898-1908. PubMed ID: 33856270
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
Ramachandran S; Thangarajan S
Metab Brain Dis; 2018 Oct; 33(5):1459-1470. PubMed ID: 29855977
[TBL] [Abstract][Full Text] [Related]
18. Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK.
Habib MZ; Tadros MG; Abd-Alkhalek HA; Mohamad MI; Eid DM; Hassan FE; Elhelaly H; Faramawy YE; Aboul-Fotouh S
Eur J Pharmacol; 2022 Jul; 927():175046. PubMed ID: 35623405
[TBL] [Abstract][Full Text] [Related]
19. Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: Role of PI3K/Akt and JAK2/NF-κB signaling pathways.
Rabie MA; Ghoneim AT; Fahmy MI; El-Yamany MF; Sayed RH
Chem Biol Interact; 2024 Apr; 393():110957. PubMed ID: 38513929
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways.
Jang M; Cho IH
Mol Neurobiol; 2016 May; 53(4):2619-35. PubMed ID: 26096705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
